Home
Conditions
Thoracic Neoplasms

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,059 public trials 1,846 recruiting studies

Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Enrolling by invitation

Maintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC)

NCT06419179

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations: University Hospital Cologne Cologne, North Rhine-Westphalia, Germany

View Trial Details

Enrolling by invitation

Real-World Assessment of Therapeutic Strategies and Survival Outcomes Following First-Line Tislelizumab Therapy in Advanced Non-Small Cell Lung Cancer

NCT06962449

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations: Shanghai Chest Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Enrolling by invitation

Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors

NCT06690216

Conditions: Astrocytoma, Bronchial Neoplasms, Carcinoma, +30 more
Locations: Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences Jinan, Shandong, China

View Trial Details

Enrolling by invitation

Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients

NCT06883136

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Degan Lu Jinan, Shandong, China

The First Affiliated Hospital of Shandong First Medical University Jinan, Shandong, China

View Trial Details

Enrolling by invitation

LORLATINIB-related HYPERLIPIDEMIA in ALK+ Non-Small Cell Lung Cancer

NCT06876675

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
Locations: Peking University Third Hospital Beijing, China

View Trial Details

Enrolling by invitation

Improving Genomic Profiling and Reducing Time to Cancer Treatment Via Targeted Use of Endoscopic Ultrasound

NCT06848738

Conditions: Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +15 more
Locations: Department of Medicine, Zealand University Hospital, Næstved Næstved, Denmark

Department of Respiratory Medicine, Odense University Hospital Odense, Denmark

Department of Medicine, Zealand University Hospital, Roskilde Roskilde, Denmark

View Trial Details

Enrolling by invitation

Chemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLC

NCT06816966

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Fujian Medical University Union Hospital, Fuzhou, Fujian, China

View Trial Details

Enrolling by invitation

Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer

NCT06773156

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Limited-stage Small Cell Lung Cancer (LS-SCLC), +8 more
Locations: The Second Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China

View Trial Details

Enrolling by invitation

FHND9041 Versus Afatinib for Non-small Cell Lung Cancer

NCT06759857

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Cancer Hospital Chinese Academy of Medical Sciences Beijing, China

View Trial Details

Enrolling by invitation

Cryobiopsy Vs. Forceps Biopsy for Peripheral Pulmonary Lesions

NCT06752395

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Pusan National University Hospital Busan, South Korea

Yeungnam University Medical Center Daegu, South Korea

Chungnam National University Hospital Daejeon, South Korea

View Trial Details

Thoracic Neoplasms

Thoracic Neoplasms trial results

Related conditions